Cambria Investment Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,249
Closed -$334K 413
2024
Q4
$334K Buy
19,249
+437
+2% +$8.39K 0.02% 305
2024
Q3
$363K Sell
18,812
-5,821
-24% -$107K 0.02% 272
2024
Q2
$404K Buy
24,633
+7,085
+40% +$110K 0.02% 213
2024
Q1
$267K Buy
+17,548
New +$276K 0.02% 316
2022
Q2
Sell
-317,682
Closed -$6.15M 279
2022
Q1
$6.15M Buy
317,682
+105,894
+50% +$1.89M 0.78% 33
2021
Q4
$3.65M Buy
+211,788
New +$3.61M 0.61% 56
2015
Q4
Sell
-1,375
Closed -$10K 221
2015
Q3
$10K Hold
1,375
﹤0.01% 270
2015
Q2
$25K Buy
1,375
+1,129
+459% +$19.4K 0.01% 189
2015
Q1
$4 Hold
246
﹤0.01% 195
2014
Q4
$3K Buy
+246
New +$3.7K ﹤0.01% 213

Other funds holding INVA

Cambria Investment Management's INVA Position: Q1 2025 in Review

Cambria Investment Management sold out of Innoviva (INVA) in Q1 2025, closing a stake of 19,249 shares — an estimated $334K sold.

Cambria Investment Management first reported a position in INVA in Q4 2014 and held it in 10 quarters. The position peaked at $6.15M in Q1 2022. 246 funds tracked by Wall St. Rank hold INVA as of Q1 2025.

  • Cambria Investment Management reported no remaining Innoviva position as of Q1 2025 after selling out during the quarter.
  • Cambria Investment Management sold 19,249 Innoviva shares in Q1 2025, an estimated $334K.
  • Cambria Investment Management first reported a position in Innoviva in Q4 2014 and held it in 10 quarters.
  • Cambria Investment Management's Innoviva position peaked at $6.15M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held Innoviva as of Q1 2025.

Based on Cambria Investment Management's 13F filing for Q1 2025, filed 15 May 2025.